☆ 4.5 Article

Prognostic evaluation of cancer associated fibrosis and tumor budding in colorectal cancer

PATHOLOGY RESEARCH AND PRACTICE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic value of desmoplastic stromal reaction, tumor budding and tumor-stroma ratio in stage II colorectal cancer

Shuxuan Fan et al.

Journal of Gastrointestinal Oncology (2022)

添加到收藏夹

Review Oncology

Tumor Stroma Ratio and Its Significance in Locally Advanced Colorectal Cancer

Luz Sullivan et al.

Summary: Colorectal cancer is the third leading cause of cancer-related death, and its incidence is increasing in younger patients. The interaction between tumor cells and the surrounding tissue or tumor microenvironment plays a crucial role in the development of colorectal cancer. Alteration to the tumor stroma is an important determinant of colorectal cancer progression.

CURRENT ONCOLOGY (2022)

添加到收藏夹

Review Oncology

Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review

Jinlai Gao et al.

Summary: Tumor-stroma ratio (TSR) is a promising prognostic indicator for colorectal cancer (CRC) patients, with low TSR associated with worse prognosis in terms of disease-free survival (DFS) and overall survival (OS). The study found significantly higher hazard ratios for patients with low TSR in stage II CRC, stage III CRC, and mixed stage CRC, suggesting a predictive relevance for poor outcomes in these patients.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Gastroenterology & Hepatology

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study

Marloes A. Smit et al.

Summary: The study evaluated the practical application of tumour-stroma ratio and tumour budding in colon cancer patients, finding that tumour-stroma ratio is a more reliable parameter in daily practice due to better reproducibility and independent prognostic value for disease-free survival.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2021)

添加到收藏夹

Article Oncology

The prognostic value of tumor-stromal ratio combined with TNM staging system in esophagus squamous cell carcinoma

Ruyuan He et al.

Summary: Tumor-stromal ratio (TSR) is a robust prognostic factor for esophagus squamous cell carcinoma (ESCC) patients, with visual inspection being reliable to assess stroma percent. The TSNM staging system outperforms the conventional TNM system in terms of discriminative ability, particularly for stage III patients.

JOURNAL OF CANCER (2021)

添加到收藏夹

Article Oncology

Tumour budding and tumour-stroma ratio in hepatocellular carcinoma

Valtteri Kairaluoma et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

G. Argiles et al.

ANNALS OF ONCOLOGY (2020)

添加到收藏夹

Review Oncology

Adjuvant Chemotherapy for Stage III Colon Cancer

Julien Taieb et al.

CANCERS (2020)

添加到收藏夹

Review Oncology

Adjuvant Chemotherapy for Stage II Colon Cancer

Sara Elena Rebuzzi et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer

Hester C. van Wyk et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Cancer-Associated Fibroblasts and Desmoplastic Reactions Related to Cancer Invasiveness in Patients With Colorectal Cancer

Nari Shin et al.

ANNALS OF COLOPROCTOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study

Ann Christina Eriksen et al.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2018)

添加到收藏夹

Article Pathology

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations

G. W. van Pelt et al.

VIRCHOWS ARCHIV (2018)

添加到收藏夹

Article Pathology

Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016

Alessandro Lugli et al.

MODERN PATHOLOGY (2017)

添加到收藏夹

Review Oncology

Role of tumor microenvironment in tumorigenesis

Maonan Wang et al.

JOURNAL OF CANCER (2017)

添加到收藏夹

Article Medical Laboratory Technology

Tumor-stroma ratio(TSR) as a potential novel predictor of prognosis in digestive system cancers: A meta-analysis

Runjin Zhang et al.

CLINICA CHIMICA ACTA (2017)

添加到收藏夹

Article Pathology

Tumor budding in colorectal cancer-ready for diagnostic practice?*'**

Viktor H. Koelzer et al.

HUMAN PATHOLOGY (2016)

添加到收藏夹

Article Oncology

Are disseminated tumor cells in bone marrow and tumor-stroma ratio clinically applicable for patients undergoing surgical resection of primary colorectal cancer? The Leiden MRD study

F. J. Vogelaar et al.

CELLULAR ONCOLOGY (2016)

添加到收藏夹

Article Pathology

Tumor Budding in Colorectal Carcinoma Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort

Rondell P. Graham et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

添加到收藏夹

Article

Prognostic Evaluation of Tumor-Stroma Ratio in Patients with Early Stage Cervical Adenocarcinoma Treated by Surgery

Tip Pongsuvareeyakul et al.

Asian Pacific Journal of Cancer Prevention (2015)

添加到收藏夹

Article Oncology

The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer

J. H. Park et al.

ANNALS OF ONCOLOGY (2014)

添加到收藏夹

Review Gastroenterology & Hepatology

Accuracy of TNM staging in colorectal cancer: a review of current culprits, the modern role of morphology and stepping-stones for improvements in the molecular era

Dordi Lea et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2014)

添加到收藏夹

Article Oncology

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

A. Huijbers et al.

ANNALS OF ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveilla006Ece, epidemiology, and end results (SEER) database

Peng Gao et al.

BMC CANCER (2013)

添加到收藏夹

Review Oncology

The Role of Tumor Stroma in Cancer Progression and Prognosis Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer

Roy M. Bremnes et al.

JOURNAL OF THORACIC ONCOLOGY (2011)

添加到收藏夹

Article Oncology

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients

N. P. West et al.

BRITISH JOURNAL OF CANCER (2010)

添加到收藏夹

Review Oncology

The pathology of tumor stromatogenesis

Alexandra Giatromanolaki et al.

CANCER BIOLOGY & THERAPY (2007)

添加到收藏夹

Article Oncology

American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer

AB Benson et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

添加到收藏夹

Review Oncology

Putting tumours in context

MJ Bissell et al.

NATURE REVIEWS CANCER (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.